TCF · THERACRYF PLC · Investor Relations
Market Cap
3.65M GBP
Shares
2.15B
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-05-15 | Focus IR Interview – Positive OX-1 Toxicology Results, Partner Interest & Human Trials | Event |
| 2026-04-24 | Investor Meet Company – Investor Update | Event |
| 2026-04-22 | ADVFN Interview – TheraCryf Strengthens Ox-1’s Path to Market with Patent Expansion and Scalable Manufacturing Breakthroughs | Event |
| 2026-01-09 | Turner Pope Webinar | Event |
| 2025-12-03 | TheraCryf plc – Half-year results to 30 September 2025 | Results publication |
| 2025-11-20 | TheraCryf plc – ShareSoc Seminar | Event |
| 2025-07-10 | TheraCryf plc – Post AGM presentation | Presentation |
| 2025-06-11 | Ox-1 – A deep dive into TheraCryf’s addiction programme | Event |
| 2025-06-03 | Investor Meet Company Presentation: Full Year Results 2025 | Presentation |
| 2025-04-03 | TheraCryf plc Investor Webinar | Event |
| 2024-11-28 | TheraCryf plc – half-year Results 2024 | Results publication |
| 2024-06-14 | TheraCryf plc – Research and Development Update | Event |
Source: https://theracryf.com/investors/